Palbociclib Yepakati CAS 1016636-76-2 Kuchena > 99.0% (HPLC) Factory

Tsanangudzo Pfupi:

Kemikari Zita: 6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-imwe

CAS: 1016636-76-2

Kuchena:> 99.0% (HPLC)

Chitarisiko: Chichena kusvika Chiedza Yellow Powder

Pakati pePalbociclib (CAS: 571190-30-2)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-imwe CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-imwe CAS 1013916-37-4

Chemical Properties:

Chemical Name	6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-imwe
Mashoko anoreva zvakafanana	Palbociclib-Pb3
Nhamba yeCAS	1016636-76-2
Nhamba yeCAT	RF-PI1849
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C13H13BrClN3O
Molecular Weight	342.63
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Ichena kusvika kuChiedza Yellow Powder
Kuchena / Analysis Method	>99.0% (HPLC)
Related Substances	<1.00%
Kurasika paKuomesa	<0.50%
Mvura (KF)	<0.50%
Test Standard	Enterprise Standard
Usage	Pakati pePalbociclib (CAS: 571190-30-2)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

FAQ:

Application:

6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one (CAS: 1016636-76-2) iri pakati pePalbociclib (CAS: 571190- 30-2).Palbociclib mushonga wekurapa ER-positive uye HER2-negative gomarara rezamu rakagadzirwa.Palbociclib inosarudza inhibitor ye cyclin-inotsamira kinases CDK4 uye CDK6.Musi waKukadzi 3, 2015, US FDA yakabvumidza Pfizer's Palbociclib (zita rekutengesa: Ibrance) kurapwa kwekenza yemazamu yepamusoro / metastatic muvakadzi vepashure.Palbociclib ndiyo yekutanga CDK4/6 inhibitor kugamuchira FDA mvumo.